Daniel O. Wilds is CEO at SCOLR Pharma, Inc. (DDD). They have made 12 open-market trades across 1 company since 2006, most recently 2008-11-19.
CIK 0001253936
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
12 open-market purchases totalling $137K since 2006, never a sale. Across 12 scored buys the stock is up 16.1% at ninety days, and 15.8 points ahead of the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| DDD | 109,000 | $302K |
Shares reported on the most recent Form 4, priced at the 2008-11-19 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -11.7% | +16.1% | +16.1% |
| Alpha | -5.9% | +15.8% | +15.8% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DDD | BUY | 2008-11-19 | 2008-11-19 | $0.90 | $5K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2008-11-12 | 2008-11-13 | $0.89 | $4K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2008-05-30 | 2008-05-30 | $1.04 | $3K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2008-05-07 | 2008-05-08 | $1.07 | $3K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2007-12-06 | 2007-12-06 | $1.34 | $13K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2007-05-16 | 2007-05-16 | $2.41 | $12K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2007-03-16 | 2007-03-16 | $2.25 | $22K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2006-11-13 | 2006-11-13 | $4.77 | $24K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2006-06-13 | 2006-06-13 | $4.93 | $5K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2006-06-12 | 2006-06-12 | $4.98 | $7K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2006-05-19 | 2006-05-22 | $5.04 | $13K | -11.7% | +16.1% | +16.1% |
| DDD | BUY | 2006-05-16 | 2006-05-22 | $5.24 | $26K | -11.7% | +16.1% | +16.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.